D-0769-2022 Class II Terminated
FDA drug recall D-0769-2022 was initiated by Preferred Pharmaceuticals, Inc. on Mar 28, 2022 and is designated Class II. Reason for recall: Out of specification results observed in dissolution during long term stability testing. The recall status is terminated (terminated May 10, 2022). Affected quantity: 791 bottles of 90 - Count.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 20, 2022
- Initiation Date
- Mar 28, 2022
- Termination Date
- May 10, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 791 bottles of 90 - Count
Product Description
Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09
Reason for Recall
Out of specification results observed in dissolution during long term stability testing.
Distribution Pattern
Nationwide in the USA and CA.
Code Information
Lots: H0221R, D3021T, D2221J, D1321X, Exp.12/31/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0769-2022
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026